common.study.topics.clinical

Early or Late Upper Extremity Mobilization After Autograft

common.study.values.description

“Early Versus Late Upper Extremity Mobilization After Autograft”

Rationale: There is currently no observational study or randomized clinical trial published evaluating the impact of early versus late mobilization in the upper extremity after split thickness skin autograft. As the current post-operative care protocols vary based on physician preference, evidence is needed to optimize post-operative rehabilitation protocols guided by evidence which optimize wound healing, extremity range of motion, graft site pain, as well as minimize risks of complications and length of stay in hospital. Objective: To determine if early mobilization is non-inferior to late mobilization of the upper extremity after split thickness skin autograft with regards to wound healing measured as percent graft take on post-operative day 5 in adult burn patients.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Recruiting patients only common.study.methods.is-healthy-yes

Early Mobilization

Range of motion exercises of the upper extremity will be performed under the guidance of the physical therapy team starting on post-operative day 1.

Late Mobilization

The patient's grafted upper extremity will be immobilized using an elbow flexion blocking splint until post-operative day 5.

participant.views.study.view.additional

participant.views.study.view.scientific-title

The EXTREMA Trial: The Impact of Early Versus Late Upper Extremity Mobilization After Split Thickness Skin Autograft on Wound Healing in Adult Burn Patients - A Single Center Non-Inferiority Randomized Clinical Trial

common.study.values.clinical-trial-id

NCT04132180

participant.views.study.view.id

en5pld